medigraphic.com

2012, Number 2

<< Back Next >>

Revista Cubana de Angiología y Cirugía Vascular 2012; 13 (2)

Atherogenic risk and heart diseases in middle-aged women

Ramos MLE, Gallardo PUJ, Cabrera ZJ, Salgado BL, Adam SD, Mahía VM

Language: Spanish
References: 24
Page:
PDF size: 102.48 Kb.


ABSTRACT

Objective: to estimate the predictive value of some risk atherogenic factors for heart diseases in the middle-aged female population.
Methods: a cross-sectional analytical study of women between 40 and 59 years of age assisted by the teaching polyclinic in El Cerro municipality was conducted. It comprised a survey to collect data on age, personal history of cardiovascular diseases, risk factors and stage of the reproductive cycle. The multiple regression method was used for data analysis.
Results: it was found that the heart diseases were associated to blood hypertension, with relative risk of 2.299 (CI: 1.251-4.225; 95 %) and to diabetes, with relative risk of 2.461 (CI: 1.244 - 4.871; 95 %).
Conclusions: in the middle-aged female population, co-morbidities and unhealthy lifestyles, which are very frequent in this population, play a major role in developing heart diseases and not the postmenopausal condition.


REFERENCES

  1. Pisabarro R. Metabolismo y climaterio: la visión de un endocrinólogo. Rev Med Uruguay. 2000;16:144-51.

  2. López A, González R. Actualización en menopausia: abordaje desde la atención primaria. Rev Valenciana Medicina Familia. 2004;15:4-9.

  3. Maturana MA, Irigoyen MC, Spritzer PM. Menopause, estrogens, and endothelial dysfunction: current concepts. Clinics. 2007;62:77-86.

  4. Ramos Morales LE, Gallardo Pérez U de J, Cabrera Zamora J, Salgado Boris L, Adam Simón D, Mahía Vilas M, et al. Riesgo aterogénico y enfermedad cardio-cerebrovascular y arterial periférica en mujeres de edad mediana. Rev Cubana Angiol Cir Vasc [Internet]. 2012 [citado 30 May 2012];12(1). Disponible en: http://bvs.sld.cu/revistas/ang/vol12_01_11/ang03111.htm

  5. Redberg RF. Cardiovascular disease in women: Expert review. Cardiovasc Ther. 2010;8(2):141-2.

  6. Dirección Nacional de Registros Médicos y Estadísticas de Salud. 2011. Edición especial [Internet]. La Habana: MINSAP; 2012 [citado 30 May 2012]. Disponible en: http://www.sld.cu/sitios/dne/

  7. Lloyd-Jones DM, Larson MG, Beiser A, Levy D. Lifetime risk of developing coronary heart disease. Lancet. 1999;353:8992.

  8. Jones DW, Chambless LE, Folsom AR, Heiss G, Hutchinson RG, Sharrett AR, et al. Risk factors for coronary heart disease in African Americans: the Atherosclerotic Risk in Communities Study, 19871997. Arch Intern Med. 2002;162:2

  9. Greenland P, Knoll MD, Stamler J, Neaton JD, Dyer AR, Garside DB, et al. Majors risk factors as antecedents of fatal and nonfatal coronary heart disease events. JAMA. 2003;290:891-7.

  10. Vasan RS, Sullivan LM, Wilson PW, Sempos CT, Sundstrom J, Kannel WB, et al. Relative importance of borderline and elevated levels of coronary heart disease risk factors. Ann Intern Med. 2005;142:393402.

  11. Lloyd-Jones DM, Leip EP, Larson MG, D'Agostino RB, Beiser A, Wilson PW, et al. Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age. Circulation. 2006;113:7918.

  12. Lloyd-Jones D, Adams R, Carnethon M, De Simone G, Ferguson TB, Flegal K, et al. Heart disease and stroke statistics-2009 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2009;119;e51-e69.

  13. Anand SS, Islam S, Rosengren A, Franzosi MG, Steyn K, Yusufali AH, et al. Risk Factors for Myocardial Infarction in Women and Men: Insights From the INTERHEART Study. Eur Heart J. 2008;29(7):932-40.

  14. Kuller LH, Arnold AM, Psaty BM, Robbins JA, O'Leary DH, Tracy RP, et al. 10-year follow-up of subclinical cardiovascular disease and risk of coronary heart disease in the Cardiovascular Health Study. Arch Intern Med. 2006;166:71-8.

  15. Aíslan E, Erdine S. 7th Meeting on Hypertension and Atherosclerosis. Expert Rev Cardiovasc Ther. 2010;8(10):13757.

  16. Sociedad Mexicana de Nutrición y Endocrinología. Consenso para la prevención de las complicaciones crónicas de la diabetes mellitus tipo 2. Diabetes y menopausia. Rev Endocrinología Nutrición. 2004;12 (2 Suppl1):S50-6.

  17. Rosano GM, itale C, Tulli A. Managing cardiovascular risk in menopausal women. Climateric. 2006;9(Suppl 1):19-27.

  18. Rossi R, Nuzzo A, Origliani G, Modena MG. Metabolic syndrome affects cardiovascular risk profile and response to treatment in hypertensive postmenopausal women. Hypertension. 2008;52(5):865-72.

  19. Kaaja RJ. Metabolic syndrome and the menopause. Menopause Int. 2008;14(1):21-5.

  20. Rosano GM, Vitale C, Marazzi G, Volterrani M. Menopause and cardiovascular disease: the evidence. Climateric. 2007;10(Suppl 1):19-24.

  21. Lahoz C, Mostaza JM. Enfermedad arterial no coronaria (I).La aterosclerosis como enfermedad sistémica. Rev Esp Cardiol. 2007;60(2):184-95.

  22. Herrera V, Rodríguez L, González S, La O Herrera I, Mas Gómez M, Valdés O, et al. La gran crisis aterosclerótica en mujeres perimenopáusicas de un área primaria de salud de La Habana. Frecuencia y factores de riesgo. Rev Cubana Aliment Nutr. 2009;19(1):26-37.

  23. Ministerio de Salud Pública. Proyecciones de la Salud Pública en Cuba para el 2015. La Habana: Editorial de Ciencias Médicas; 2006.

  24. Kuller LH. Cardiovascular disease is preventable among women. Expert Rev Cardiovasc Ther. 2010;8(2):175-87.




2020     |     www.medigraphic.com